Topical Vitamin A (Retinol)

This page as PDF · Summary

1. What Retinol Is

Retinol is the alcohol form of vitamin A. It belongs to the fat-soluble vitamins and is applied topically in dermatological and cosmetic preparations. Decisive for the classification of all studies: retinol does not act directly at the skin cell but is enzymatically converted via retinal to retinoic acid, which binds to retinoic acid receptors and influences gene transcription. From this precursor status it follows that the effect on the skin depends not only on the amount applied but also on the cell’s conversion capacity. This is the point at which studies on retinol differ from studies on retinoic acid.

The second level is that of measurement. Studies on topical retinol record very different things: the activity of collagen-degrading matrix metalloproteinases and collagen accumulation in human skin cells, clinical features such as wrinkle depth or pigmentation, and tolerability. These levels are not interchangeable. A finding in human skin cells is preclinical: it describes a mechanism, not a skin or disease course. An observational finding in humans describes an association, not a tested effect. In addition there is the diversity of forms: retinol, retinyl esters and retinoic acid are chemically different, are taken up differently and are dosed and formulated differently in studies. Comparisons between studies are therefore possible only to a limited extent. Plausible: Part of the differences between results is attributable to vehicle, concentration and stability of the preparation.

2. What the Studies Show in Detail

The key human studies and the most important reviews — by application area, with population, duration, preparation, measure and result as reported in the original papers. Numbers appear only where the study states them.

Distribution of controlled human studies by application area — the numbers are not additive because one study may be assigned to several areas:

Olfactory Disorders After Infections

The only study that examines topical vitamin A itself as the tested active substance is a retrospective cohort study of 170 patients with olfactory disorders after infections or trauma (age 18 to 70 years, mean age 52 years) 6. 46 patients received olfactory training only, the remaining 124 received olfactory training plus topical vitamin A. The vitamin A was applied topically in the head-back position at 10 000 IU per day for 8 weeks; training lasted 12 weeks. Olfactory function was measured with the Sniffin’ Sticks test kit, which records threshold, discrimination and identification; follow-up took place approximately 10 months after the first measurement 6.

When the change in score after treatment was compared, olfactory training plus vitamin A produced a significantly greater improvement than training alone, both in the discrimination score across all patients (1.4 points, p = 0.008) and in threshold and discrimination in patients after infection 6. The study therefore provides an initial indication that topical vitamin A in addition to olfactory training can improve measured olfactory function.

The study is retrospective in design, allocation to the vitamin A group was not randomised, and the analysis separates patients after infection from those after trauma 6. What is missing is a prospective, randomised investigation that controls allocation, matches baseline olfactory performance between the groups and tests the effect beyond the follow-up of approximately 10 months 6.

Skin

For the skin there is a 2010 review on nutrition and psoriasis that evaluates randomised controlled trials on various agents. It notes that randomised controlled trials have demonstrated the efficacy of topical vitamin A derivatives in psoriasis. For the topical vitamin A derivatives the work gives no participant numbers, no duration of use and no effect sizes; it summarises the state of research without presenting individual results.

A retrospective analysis of 480 patients in South Africa and Germany examined percutaneous collagen induction for fine wrinkles, lax skin, scars and stretch marks 29. The patients were prepared at least 4 weeks before the procedure with topical vitamin A and vitamin C cosmetic creams 29. However, what was measured was the effect of the collagen induction itself: histological examination in 20 patients showed a clear increase in collagen and elastin deposition after 6 months, and after 1 year the epidermis exhibited 40 per cent thickening of the stratum spinosum 29. Patients in Germany rated their improvement on average between 60 and 80 per cent 29.

In this analysis the vitamin A cream was part of the preparation, not the tested active substance; an independent contribution of vitamin A to skin appearance therefore cannot be derived from the data 29. Hypothesis: Preparation with vitamin A could alter the baseline condition of the skin before the procedure, yet without a comparison group without this preparation this remains an open question 29. What is missing is a controlled investigation that tests topical vitamin A alone against a vehicle control on skin appearance and histology.

Inflammatory Processes, Oncology and Safety

For topical vitamin A in inflammatory skin diseases, in oncology and for tolerability a dedicated controlled study is still outstanding. Psoriasis is the only inflammatory condition for which the present review classifies topical vitamin A derivatives. Whether topical vitamin A acts in other inflammatory dermatoses, whether it prevents or alleviates mucosal inflammation during chemotherapy and how frequently it triggers contact reactions are open questions that require a dedicated study.

A robust test would have to compare topical vitamin A against a vehicle control, match duration of use and baseline skin condition between the groups and capture both clinical and histological endpoints. For tolerability, contact sensitisation and irritation would need to be recorded separately, because both can differ with topical retinoids. As long as such data are outstanding, the classification of topical vitamin A in these areas remains a testable question and not a settled judgement.

Overall Picture

Across the areas one observation stands out: topical vitamin A is used in dermatology, and the review on psoriasis classifies topical vitamin A derivatives as effective. The only work that examines topical vitamin A itself as the tested active substance, however, concerns not the skin but the nose: the retrospective cohort study in 170 patients with olfactory disorders 6. There the application was topical, dose and duration were defined, and the effect was measured with a validated test 6.

For the skin the situation remains open: the review gives no participant numbers or effect sizes for topical vitamin A derivatives, and in the collagen-induction analysis vitamin A was only part of the preparation, not the tested active substance 29. Thus a controlled investigation with vehicle control and clear endpoints is still outstanding for topical vitamin A on the skin. The olfactory study shows that such a test is feasible and provides the impetus to conduct it for the skin as well 6.

3. How Robust the Research Is

Research on topical vitamin A is broad and unevenly distributed. The largest share consists of observational human studies and basic-science work; controlled human studies are markedly rarer. Within the controlled works the emphasis lies clearly on skin and tolerability; gut, oncology, metabolism, immune system, inflammation, bone and bioavailability are each represented by only single works. Skin is therefore the only application area with a broader controlled base, and even there the tolerability assessment stands on equal footing with the assessment of clinical features.

Methodologically the field has one strength and one weakness. The strength is the mechanistic basis: a dense body of basic-science and cell-biological work describes the steps by which vitamin A reaches the skin cell. The weakness lies at the clinical level: the controlled human studies are limited in number, their endpoints are heterogeneous, and a substantial proportion of the frequently cited controlled works in the field examine other vitamins. Anyone wishing to assess the data situation for retinol must therefore distinguish three levels: the preclinical mechanistic basis, the human observation and the controlled tests that have vitamin A itself as their subject.

4. What Is Frequently Claimed — and What the Data Provide

5. Profile: Molecule and Charge

Topical vitamin A (retinol) is not a single molecule but a mixture — there is no molecular formula and no fixed molecular mass. What can be described are functional groups, charge behaviour and redox properties; that is exactly what the next section addresses.

6. Charge, Electrons, Radicals

Radicals and redox are central to the studies presented, though almost exclusively in relation to vitamin E, not retinol. In humans, studies on acne describe the involvement of free-radical oxidation in pathogenesis and the need for further research on the use of topical antioxidants 17 19 20.

For retinol itself the material contains no measurement of charge, cation exchange or electron transfer. The animal findings concern vitamin E: in myringotomised tympanic membranes ROS levels fell significantly after topical application in group 4 compared with untreated animals in group 2 21, while the decline in group 5 was not statistically significant 21. A basic study on the cornea after photorefractive keratectomy links free-radical formation with neutrophilic infiltration 22. In humans, only tolerability and application 18 as well as the involvement of reactive oxygen species in acne abnormalities 18 19 have been recorded so far. It remains to be clarified whether redox or charge parameters for retinol can be measured directly in humans.

7. Interactions with Other Substances

Which other substances on the platform have been jointly investigated or discussed with this substance in human studies and reviews — combination, comparison or shared mechanism of action. The number indicates studies in which both appear.

No interactions with medicines, nutrients or other substances have yet been described for topical retinol. The studies that examine combinations of topical active ingredients concern other substances: vitamin-D3 analogues with corticosteroids and narrow-band UVB 4 25, calcipotriol with platelet-rich plasma in alopecia areata 23 23, ascorbic acid with a trichloroacetic-acid peel in melasma 24 24 and vitamin E in a topical preparation 27. These studies cannot be transferred to retinol because they investigate a different substance and a different procedure.

For topical retinol the examination of interactions remains outstanding. It remains to be clarified whether simultaneously applied medicines or nutrients alter uptake into the skin, whether enzymes of retinol metabolism are inhibited or induced, and whether combinations enhance or attenuate the effect. Studies on other substances provide an indication of the direction such questions might take: with vitamin-D3 analogues an enhanced effect was described in combination with corticosteroids and narrow-band UVB 4, and a vitamin-D3 ointment preparation was associated with hypercalcaemia when used together with thiazide diuretics 26. Whether comparable findings appear for retinol is open.

8. Overdosage, Tolerability, Limits

The value is shown in comparison with further therapies each with more than 80 participants; the rates ranged from 17.6 % to 52.3 % 3. In this study tretinoin therefore belongs to the therapies with the lowest recorded adverse-event proportion. This classification refers to the named condition, not to application on healthy skin.

It remains open which dose and which upper limit apply for topical retinol and which contraindications exist. It must be clarified whether the recorded adverse-event proportion of 10.1 % for tretinoin 3 also applies to retinol at lower concentration and how the rate changes with longer use or larger treated area. It likewise remains to be established whether the reactions described for retinoids — inflammatory reactions, hyperpigmentation, pain and erythema 28 — occur in a dose-dependent manner and which concentrations are regarded as tolerable. A study that examines retinol in defined concentrations over a fixed period in a sufficiently large group and systematically records adverse effects would clarify these questions.

9. The Most Robust Studies

Ordered by strength of evidence, not by familiarity: reviews and studies with many participants first. The complete evaluation comprises considerably more studies; the most robust ones are shown here.

Controlled Studies in Humans

• 1 Potential Harms of Ocular and Periorbital Topical Vitamin A Application: A Systematic Review and Meta-Analysis (2026) — Review article, 10.794 participants
• 2 Efficacy of topical vitamin C in melasma and photoaging: A systematic review (2023) — Review article, 139 participants
• 3 Comparison of the Efficacy of Melasma Treatments: A Network Meta-Analysis of Randomized Controlled Trials (2021) — Review article, 80 participants
• 4 Vitamin D and its Analogs in Treatment of Mild to Moderate Alopecia Areata: Systematic Review and Meta-Analysis (2026) — Review article
• 5 Topical Vitamin C in the Prevention and Treatment of Actinic Keratoses and Nonmelanoma Skin Cancers: A Systematic Scoping Review (2026) — Review article, 21 participants
• The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients … (2004) — 828 participants
• 6 Intranasal vitamin A is beneficial in post-infectious olfactory loss (2017) — 170 participants
• 7 Long-term maintenance therapy for vulvar lichen sclerosus: the results of a randomized study comparing topical vitamin E with an emollient (2013) — 156 participants
• Effect of Vitamin D Supplementation on Psoriasis Severity in Patients With Lower-Range Serum 25-Hydroxyvitamin D Levels: A Randomized Clinical Trial (2023) — 122 participants
• Vitamin D and wound healing: Assessing skin barrier function and implications for chloasma treatment (2024) — 480 participants
• 8 Double-blind, half-face study comparing topical vitamin C and vehicle for rejuvenation of photodamage (2002)
• Proactive maintenance therapy with a topical corticosteroid for vulvar lichen sclerosus: preliminary results of a randomized study (2013) — 27 participants
• 9 Serial controlled N-of-1 trials of topical vitamin E as prophylaxis for chemotherapy-induced oral mucositis in paediatric patients (2007) — 23 participants
• 10 The effects of topical vitamin K on bruising after laser treatment (2002) — 22 participants
• 11 Topical vitamin B12--a new therapeutic approach in atopic dermatitis-evaluation of efficacy and tolerability in a randomized placebo-controlled … (2004) — 49 participants
• Nutrition and psoriasis (2010)
• 12 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment … (2005)
• 13 Yellow nail syndrome in three siblings: a randomized double-blind trial of topical vitamin E (2006)
• 14 Evaluation of topical vitamin B(12) for the treatment of childhood eczema (2009)
• Effectiveness of intralesional vitamin D3 injection in the treatment of common warts: Single-blinded placebo-controlled study (2019) — 30 participants
• Superiority of a vitamin B12-barrier cream compared with standard glycerol-petrolatum-based emollient cream in the treatment of atopic dermatitis: A … (2017) — 22 participants
• 15 Bateman purpura (dermatoporosis): a localized scurvy treated by topical vitamin C - double-blind randomized placebo-controlled clinical trial (2018) — 18 participants
• 16 Topical vitamin D3: A randomized controlled trial (RCT) (2018)
• Efficacy and tolerance of topical calcitriol 3 microg g(-1) in psoriasis treatment: a review of our experience in Poland (2001)

10. Summary

In humans the smell study shows: In 170 patients with loss of smell after infection or trauma the score change under smell training plus topical vitamin A was greater than under training alone, in the discrimination score across all patients 1.4 points at p = 0.008 6. For the skin the analysis in 480 patients examined vitamin A not as an active substance but as part of the preparation 29. In human skin cells the most-cited work with vitamin A in the title describes inhibition of collagen-degrading enzymes and collagen enrichment; this finding is preclinical. The mechanistic part is therefore the densest area of the field; clinical testing on skin remains open.

From the precursor position it follows that the effect on the skin does not depend solely on the amount applied but on the cell’s conversion capacity. Hypothesis: When topical vitamin A derivatives are considered together the data on retinol appear more robust than when examined separately. Hypothesis: Preparation of the skin with vitamin A before collagen induction could alter the skin’s baseline; without a comparison group lacking this preparation the question remains open 29.

A robust test would have to compare topical vitamin A as the sole active substance against a vehicle control, match application duration and baseline skin condition between groups, and capture both clinical and histological endpoints; for tolerability contact sensitisation and irritation would need to be recorded separately. For olfactory disorders a prospective randomised study would be required that controls allocation, matches baseline olfactory performance between groups and examines the effect beyond the approximately 10-month follow-up 6. It also remains open whether topical vitamin A acts in other inflammatory dermatoses and whether it prevents or alleviates mucosal inflammation during chemotherapy.

11. What Remains Open

• Conversion: How much applied retinol is converted to retinoic acid in the skin, and how strongly does this differ between individuals and skin areas?
• Endpoints: Which clinical features — wrinkle depth, collagen density, elasticity — have been examined under controlled conditions for retinol itself, and in which vehicle?
• Tolerability: Can a concentration be maintained over longer periods that is both effective and tolerable? A long-term study would clarify this question.

12. Further Paths

Topics, modes of action and pathways in which this substance occurs — for all those who wish to look beyond the substance.

• Interaction network